Magyar Czéfjog : a czégjegyzék-birói felügyelet szabályainak kézikönyve. Az erre vonatkozó törvények, rendeletek és birói határozatok összegyüjtésével és a Budapesti kir, kereskedelmi és váltótörvényszék gyakorlatára különös figyelemmel /

Mode of access: Internet.

Interaction entre le récepteur GABA�₁ et le canal potassique Kir 3

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Interaction entre le récepteur GABA�₁ et le canal potassique Kir 3

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Copto-Arabic Universal Chronography. Between Antiquity, Judaism, Christianity and Islam The K. al-Tawārīkh of N. al-Khilāfa Abū Shākir Ibn al-Rāhib (655 Heg. / 973 Mart. / 1257 Chr. / 1569 Alex. / 6750 AM)

La obra histórica del erudito y enciclopedista de la edad de oro de la literatura árabe copta, de la cual el Dr. Samuel Moawad (Munster) está preparando una edición, representa en realidad una colección de tres tratados divididos artificialmente en 51 capítulos secuenciales. El núcleo cronológico es precedido por un largo tratado con 47 capítulos sobre cálculos astronómicos y eclesiásticos así como épocas históricas y calendarios de diferentes naciones. La parte histórica propia (ch. 48-50), de los cuales el llamado Chronicon orientale representa una deficiente revisión anónima, trata sucesivamente de historia universal, dinastías islámicas y patriarcas coptos. Un sumario histórico, así como dogmático, de los primeros siete/ocho concilios de la Iglesia cristiana (cap. 51) termina la compilación entera. El conocido historiador al-Makin Ibn al-.Amid hace un gran uso de la labor de su contemporáneo y, al parecer a través de él, los grandes historiadores musulmanes: Ibn Khaldun, Maqrizi o Qalqashandi hacen mención continua de Ibn al-Rahib. Más tarde en el siglo XVI, el K. al-Tawarikh fue traducido en etiópico y tuvo un gran impacto en la literatura histórica y computacional de los etíopes.

Consistent HMM parameter estimation using Kerridge inaccuracy rates

In this paper, we propose a novel online hidden Markov model (HMM) parameter estimator based on Kerridge inaccuracy rate (KIR) concepts. Under mild identifiability conditions, we prove that our online KIR-based estimator is strongly consistent. In simulation studies, we illustrate the convergence behaviour of our proposed online KIR-based estimator and provide a counter-example illustrating the local convergence properties of the well known recursive maximum likelihood estimator (arguably the best existing solution).

Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis

Objectives: To assess the possible association of killer immunoglobulin-like receptor (KIR) genes, specifically KIR3DL1, KIR3DS1 and KIR3DL2, with ankylosing spondylitis (AS). Methods: 14 KIR genes were genotyped in 200 UK patients with AS and 405 healthy controls using multiplex polymerase chain reaction. Sequence-specific oligonucleotide probes were used to subtype 368 cases with AS and 366 controls for 12 KIR3DL2 alleles. Differences in KIR genotypes and KIR3DL2 allele frequencies were assessed using the χp2p test. Results: KIR3DL1 and KIR3DS1 gene frequencies were very similar in cases with AS and controls (odds ratio = 1.5, 95% confidence interval 0.8 to 3.0, and odds ratio = 1.02, 95% confidence interval 0.2 to 5.3, respectively). KIR3DL2 allele frequencies were not significantly different between cases with AS and controls. Conclusions: Neither the KIR gene content of particular KIR haplotypes nor KIR3DL2 polymorphisms contribute to AS.

Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis

The advent of high-throughput SNP genotyping methods has advanced research into the genetics of common complex genetic diseases such as ankylosing spondylitis (AS) rapidly in recent times. The identification of associations with the genes IL23R and ERAP1 have been robustly replicated, and advances have been made in studies of the major histocompatibility complex genetics of AS, and of KIR gene variants and the disease. The findings are already being translated into increased understanding of the immunological pathways involved in AS, and raising novel potential therapies. The current studies in AS remain underpowered, and no full genomewide association study has yet been reported in AS; such studies are likely to add to the significant advances that have already been made.

Genetics and the pathogenesis of ankylosing spondylitis

Purpose of review The field of genetic research in ankylosing spondylitis (AS) is advancing rapidly. The purpose of this review is to outline recent findings, particularly, in regard to genetic studies of the major histocompatibility complex (MHC) and the non-MHC genes IL23R, ERAP1, and killer cell immunologlobulin-like receptor (KIR) complex, in AS. Recent findings: Convincing evidence has been reported for the existence of further non-B27 MHC genes involved in AS. Strong, replicated association has been reported with IL23R and ERAP1 and AS. The IL23R finding strongly implicates the TH17 lymphocyte system in AS aetiopathogenesis. Suggestive evidence of a role for KIR gene polymorphism in AS exists, but definitive findings are awaited. Summary: The findings suggest that further genome-wide studies in large case-control cohorts are likely to be very productive in this disease. The IL23R findings and subsequent immunological investigations suggest that targeted intervention in the TH17 system is likely to have major therapeutic benefit, as it does in the genetically related diseases, inflammatory bowel disease and psoriasis.

Genetics of ankylosing spondylitis

Purpose of Review Over the past 3 years, several new genes and gene deserts have been identified that are associated with ankylosing spondylitis (AS). The purpose of this review is to discuss the major findings of these studies, and the answers they provide and questions they raise about the pathogenesis of this common condition. Recent Findings: Five genes/genetic regions have now definitively been associated with AS [the major histocompatibility complex (MHC), IL23R, ERAP1, 2p15 and 21q22]. Strong evidence to support association with the disease has been demonstrated for the genes IL1R2, ANTXR2, TNFSF15, TNFR1 and a region on chromosome 16q including the gene TRADD. There is an overrepresentation of genes involved in Th17 lymphocyte differentiation/activation among genes associated with AS and the related diseases inflammatory bowel disease and psoriasis, pointing strongly to this pathway as playing a major causative role in the disease. Increasing information about differential association of HLA-B27 subtypes with disease suggests a hierarchy of strength of association of those alleles with AS, providing a useful test as to the validity of different potential mechanisms of association of HLA-B27 with AS. The mechanism underlying the association of the gene deserts, 2p15 and 21q22, suggests the involvement of noncoding RNA in AS etiopathogenesis. Summary: The increasing list of genes identified as being definitely involved in AS provides a useful platform for hypothesis-driven research in the field, providing a potential alternative route to determining the underlying mechanisms involved in the disease to research focusing on HLA-B27 alone.

Breakthroughs in genetic studies of ankylosing spondylitis

Ankylosing spondylitis (AS), the prototypic seronegative arthropathy, is known to be highly heritable, with >90% of the risk of developing the disease determined genetically. As with most common heritable diseases, progress in identifying the genes involved using family-based or candidate gene approaches has been slow. The recent development of the genome-wide association study approach has revolutionized genetic studies of such diseases. Early studies in ankylosing spondylitis have produced two major breakthroughs in the identification of genes contributing roughly one third of the population attributable risk of the disease, and pointing directly to a potential therapy. These exciting findings highlight the potential of future more comprehensive genetic studies of determinants of disease risk and clinical manifestations, and are the biggest advance in our understanding of the causation of the disease since the discovery of the association with HLA-B27.

钾离子通道Kir2.1/C-末端功能区的分子动力学模拟

<正>内向整流型钾离子通道(Kir,inwardlyrectifyingpotassium)在细胞激活、细胞内外钾离子K~+的动态平衡、胰岛素分泌等细胞生理过程中起重要作用。而细胞内各种不同因素和第二信使对Kir的调控则是实现其不同生理功能的途径。已有实验结果表明,4,5二磷酸磷脂酰肌醇(PIP2,phosphatidylinositol4,5-bisphosphate)与Kir相互作用的强弱决定了Kir对各种调控因素的响应程度。根据Kir2.1与Kir3.1胞内C-末端X-ray

Single cell proteomics microchip to profile immune function, with applications in stem cell biology, translational disease mechanism study and clinical therapeutics monitoring

In response to infection or tissue dysfunction, immune cells develop into highly heterogeneous repertoires with diverse functions. Capturing the full spectrum of these functions requires analysis of large numbers of effector molecules from single cells. However, currently only 3-5 functional proteins can be measured from single cells. We developed a single cell functional proteomics approach that integrates a microchip platform with multiplex cell purification. This approach can quantitate 20 proteins from >5,000 phenotypically pure single cells simultaneously. With a 1-million fold miniaturization, the system can detect down to ~100 molecules and requires only ~104 cells. Single cell functional proteomic analysis finds broad applications in basic, translational and clinical studies. In the three studies conducted, it yielded critical insights for understanding clinical cancer immunotherapy, inflammatory bowel disease (IBD) mechanism and hematopoietic stem cell (HSC) biology.

To study phenotypically defined cell populations, single cell barcode microchips were coupled with upstream multiplex cell purification based on up to 11 parameters. Statistical algorithms were developed to process and model the high dimensional readouts. This analysis evaluates rare cells and is versatile for various cells and proteins. (1) We conducted an immune monitoring study of a phase 2 cancer cellular immunotherapy clinical trial that used T-cell receptor (TCR) transgenic T cells as major therapeutics to treat metastatic melanoma. We evaluated the functional proteome of 4 antigen-specific, phenotypically defined T cell populations from peripheral blood of 3 patients across 8 time points. (2) Natural killer (NK) cells can play a protective role in chronic inflammation and their surface receptor – killer immunoglobulin-like receptor (KIR) – has been identified as a risk factor of IBD. We compared the functional behavior of NK cells that had differential KIR expressions. These NK cells were retrieved from the blood of 12 patients with different genetic backgrounds. (3) HSCs are the progenitors of immune cells and are thought to have no immediate functional capacity against pathogen. However, recent studies identified expression of Toll-like receptors (TLRs) on HSCs. We studied the functional capacity of HSCs upon TLR activation. The comparison of HSCs from wild-type mice against those from genetics knock-out mouse models elucidates the responding signaling pathway.

In all three cases, we observed profound functional heterogeneity within phenotypically defined cells. Polyfunctional cells that conduct multiple functions also produce those proteins in large amounts. They dominate the immune response. In the cancer immunotherapy, the strong cytotoxic and antitumor functions from transgenic TCR T cells contributed to a ~30% tumor reduction immediately after the therapy. However, this infused immune response disappeared within 2-3 weeks. Later on, some patients gained a second antitumor response, consisted of the emergence of endogenous antitumor cytotoxic T cells and their production of multiple antitumor functions. These patients showed more effective long-term tumor control. In the IBD mechanism study, we noticed that, compared with others, NK cells expressing KIR2DL3 receptor secreted a large array of effector proteins, such as TNF-α, CCLs and CXCLs. The functions from these cells regulated disease-contributing cells and protected host tissues. Their existence correlated with IBD disease susceptibility. In the HSC study, the HSCs exhibited functional capacity by producing TNF-α, IL-6 and GM-CSF. TLR stimulation activated the NF-κB signaling in HSCs. Single cell functional proteome contains rich information that is independent from the genome and transcriptome. In all three cases, functional proteomic evaluation uncovered critical biological insights that would not be resolved otherwise. The integrated single cell functional proteomic analysis constructed a detail kinetic picture of the immune response that took place during the clinical cancer immunotherapy. It revealed concrete functional evidence that connected genetics to IBD disease susceptibility. Further, it provided predictors that correlated with clinical responses and pathogenic outcomes.

查尔酮异构酶基因过表达对新疆雪莲类黄酮生物合成的调控

新疆雪莲（Saussurea involucrata Kar. et Kir.）是我国名贵中药材，其主要药用活性成分为黄酮类化合物。目前人们对新疆雪莲及它的黄酮类化合物的需求日益增多，但雪莲的人工栽培技术尚未成熟，在野生状态下，新疆雪莲只能生长在海拔4,000到5,000米的雪山上，现在由于过度采挖已濒临灭绝。为解决雪莲资源匮乏，提高雪莲中黄酮类成分的含量，本研究通过基因工程手段利用发根农杆菌将黄酮代谢途径中的关键酶－查尔酮异构酶（CHI）基因导入新疆雪莲，产生转基因新疆雪莲毛状根及再生苗，以期提高新疆雪莲的黄酮类物质含量，进行新疆雪莲黄酮类物质的生产。主要结果如下： 　　1．对克隆到的水母雪莲查尔酮异构酶基因（Smchi）进行功能分析。转Smchi正义、反义烟草的CHI酶活性实验结果表明，转Smchi正义的烟草CHI酶活性比对照提高3-6倍，而转反义Smchi基因的烟草CHI酶活性比对照则显著降低。分析不同株系的转基因烟草和对照烟草的黄酮含量和花色素含量表明，转Smchi正义的烟草积累比对照显著增高水平的总黄酮，其中株系CS-5黄酮含量是对照的6倍，转Smchi反义的烟草则积累较低水平的总黄酮，而且转基因烟草的总黄酮含量与Smchi基因的表达水平和CHI酶活性成正相关。但不论转Smchi基因正义或反义方向的烟草，其花色素含量和对照相比均没有发生显著变化。进一步对转基因烟草的黄酮成分进行分析，发现烟草中的主要黄酮成分芦丁在转Smchi正义烟草中有很高的积累。 　　2．发根农杆菌介导法将Smchi基因导入新疆雪莲，得到转Smchi基因的新疆雪莲毛状根。实验发现，35S-chi转基因对毛状根的生长没有显著影响，但35S-chi转基因毛状根能够合成显著提高水平的芹菜素和总黄酮，其中根系C46经过35 d培养，能产生32.1 mg/L的芹菜素和647.8 mg/L的总黄酮，分别是对照根系的12倍和4倍;不同根系的Smchi基因表达水平、CHI酶活性和芹菜素含量成正相关。本研究为通过基因工程手段提高新疆雪莲毛状根芹菜素和总黄酮含量提供了一个有效方法。 　　3．在1/2MS附加GA1.5 mg/L的培养基上，新疆雪莲毛状根的不定芽再生频率高且不定芽生长健壮。再生苗在MS+BA1.0 mg/L+NAA0.1 mg/L的培养基上继代培养生长量较大，经过20 d的培养，35S-chi转基因新疆雪莲再生苗株系（C17、C27、C46）、对照再生苗（Control-1）和正常试管苗（Control-2）之间生长量差异不显著，增殖倍数都在7倍左右;实验还发现，毛状根再生苗比各自来源的毛状根的芹菜素和总黄酮含量下降了20-30%，但转基因再生苗的芹菜素和总黄酮含量比Control-1和Control-2都有显著提高，其中C46芹菜素和总黄酮含量分别为1.86 mg/g 干重和37.3 mg/g干重，分别是Control-1的12倍和 2.4 倍，Control-2的4 倍和1.6倍。这些结果表明由毛状根诱导出的再生苗可作为增强目标次生代谢产物生产的另外一个有效来源。 　　

雪莲细胞培养物中黄酮类物质代谢调控及其生物活性成份分析

水母雪莲（Saussurea medusa Maxim.）和新疆雪莲（Saussurea involucrata Karel. et Kir.）是我国珍稀的药用植物资源，具有清热解毒、止痉镇痛、敛伤、消肿及治疗热病、风湿等多种功效。雪莲的主要药用成份为紫丁香甙（Syringin）、芦丁(Rutin)、高车前素（Hispidulin）和Jaceosidin等苯基丙酸类（phenylpropanoid）和黄酮类（flavonoids）物质。最新的药理研究表明，上述物质还具有抗菌消炎、保肝降压、延缓衰老和抑制癌细胞增殖等重要的研发价值。 雪莲生境恶劣，生长缓慢，人工引种困难，加上长期掠夺性采挖，已使雪莲处于灭绝的边缘。为了保存国家珍稀植物品种，保护生态环境，满足临床上对雪莲药物的需求，本研究在雪莲组织培养的基础上，应用诱导子添加技术和毛状根培养技术对雪莲中具有重要药用价值的次生代谢物质进行调控，并对雪莲MYB类转录因子的功能进行了初步探索，为保护珍稀植物资源、维护生态环境、开发野生雪莲替代产品、缩短雪莲药用成份的生产周期奠定了基础。另外，分析了野生雪莲和雪莲培养物中主要生物活性成份的种类及含量，为今后雪莲药理药效研究及品质评价奠定了基础。 为了提高雪莲黄酮的产量，满足工业化生产的需要，在细胞培养水平上，通过添加茉莉酸甲酯（MJ），对雪莲黄酮类物质的代谢进行调控。研究了诱导子的添加时间、添加浓度对水母雪莲红色系悬浮细胞的生物量和总黄酮产量的影响。发现在细胞培养的指数期（第9天）添加5.0 µmol/L的MJ，可以使总黄酮产量提高2.4倍（1134.5 ± 63.86 mg/L），而雪莲细胞干重（dw）仅比对照提高23.8 %（20.4 ±0.27 g/L）。另外，细胞中苯丙氨酸裂解酶（PAL）的活性分析表明，MJ添加后PAL活性的增加与雪莲总黄酮含量增长之间存在相关性。 在器官培养水平上，对雪莲毛状根的诱导频率及其培养条件进行了研究。结果表明，选择发根农杆菌R1601侵染预培养2天的新疆雪莲根段外植体，毛状根的诱导效率可达到83 %。毛状根的冠瘿碱检测、PCR和Southern分析表明，Ri质粒中的T-DNA已整合到植物基因组中并稳定表达。以新疆雪莲毛状根为外植体，能够容易地获得再生芽。在含有1.0 mg/L 6-BA的MS固体培养基上，其再生频率高达91 ± 5.9 %，是其正常根的2.4倍。而水母雪莲在该培养条件下，仅有少量的畸形芽出现。进而对毛状根的培养条件进行初步研究，结果表明在无激素附加的MS液体培养基中，新疆雪莲的HR1601根系在一个培养周期内（32 天），其生物量能够达到接种量的16倍，而紫丁香甙含量（43.5 ± 1.13 mg/g dw）能够达到野生雪莲的83倍。从而显示了雪莲毛状根培养体系的优良特性。 在基因水平上，对雪莲黄酮类物质代谢调控的研究已经展开。玉米P基因编码的Myb类转录因子能够调节黄酮类物质代谢途径关键酶基因的表达。根据P基因的保守序列设计引物，从雪莲细胞培养物中获得了SmP基因。核酸序列分析表明，SmP基因与烟草中涉及苯丙素类物质代谢途径的LBM 1、LBM 3和MybAS 1基因具有较高的一致性，分别为66 %、60 %和61 %。因此为了研究雪莲SmP基因的功能，构建了正义表达载体，并与先前构建好的反义表达载体分别导入烟草，分析了转基因植株的形态特征及黄酮类物质的含量变化。其中，约有30 %转反义SmP基因的株系表现叶片皱缩、叶脉紊乱、主侧脉角度缩小、叶片、花瓣失去对称性以及花粉败育等性状。 另外，通过正交试验设计优化了雪莲提取工艺的条件，并对雪莲细胞提取物进行了分离纯化。正交试验设计结果表明，温度对雪莲黄酮提取效率的影响极为显著，而分批多次提取比一次性浸提，能够收到较好的提取效果。考虑到工业生产中的实际问题，推荐在60 ℃水浴条件下，采用50 %乙醇对雪莲样品连续浸提2次的方案。对雪莲提取物的纯化研究表明，雪莲成份复杂，仅依靠单一的分离手段，往往难以奏效。另外，野生雪莲及雪莲培养物中生物活性成份的比色法、HPLC（High Performance Liquid Chromatography）、LC-ESI-MS（Liquid Chromotagraphy Electrospray Ionization Mass Spectrometry）分析表明，传统的NaNO2-AlCl3 法测定雪莲总黄酮的含量，结果偏高，不利于雪莲黄酮的实验室研究分析与今后工业化生产的质量监控。而AlCl3 法的显色反应较为特异，今后有望取代NaNO2-AlCl3 法，作为雪莲类药材品质评价的标准。而HPLC-DAD结合LC-ESI-MS可以对雪莲中的主要生物活性成份进行较为准确的定性分析，从而解决了由于缺乏相应的雪莲化合物标准品而难以对雪莲中的成份进行定性定量分析及比较的难题。最后综合利用上述分析方法，对雪莲细胞培养物中的花素类物质进行了分析。结果表明，雪莲细胞中至少含有7种花色素类物质，分别为矢车菊素-3-O-葡萄糖甙及其衍生物、天竺葵素糖甙衍生物和芍药色素糖甙衍生物。